Anhedonia is the reduced ability to feel pleasure or interest in things that used to matter to you. The word comes from Greek, meaning without pleasure. It is one of the two core symptoms of major depression, alongside low mood, and a diagnosis requires at least one of them. People describe food losing its taste, music going flat, friends feeling like effort, and hobbies feeling pointless. Researchers distinguish anticipatory anhedonia, not looking forward to things, from consummatory anhedonia, not enjoying them while they happen; depression tends to affect anticipation and motivation most.
Anhedonia involves the brain's reward circuitry, particularly dopamine pathways connecting the ventral striatum and prefrontal cortex. That is relevant to treatment because serotonin-focused antidepressants sometimes lift sadness and anxiety while leaving anhedonia behind, and residual anhedonia predicts relapse. Options with more effect on dopamine and motivation include bupropion, certain augmentation strategies, behavioral activation in therapy, and the interventional treatments. Deep TMS targets the prefrontal cortex that regulates reward, and esketamine's rapid effects on glutamate signaling have shown benefits for anhedonia in clinical studies. Anhedonia also appears in schizophrenia as a negative symptom, in PTSD, in Parkinson's disease and in substance withdrawal, so your provider will consider the full picture. At Stedfast Psychiatry we ask about interest and pleasure specifically, not just mood, and we treat persistent anhedonia as unfinished business rather than an acceptable endpoint.